AAAAAA
Results:
1-12
|
Results: 12
Authors:
VASSILOMANOLAKIS M
TSOUSSIS S
EFREMIDIS A
Citation: M. Vassilomanolakis et al., LONG-LASTING, GRADE-IV, ORTHOSTATIC HYPOTENSION AFTER A SINGLE-CYCLE COMBINATION CHEMOTHERAPY WITH PACLITAXEL AND CISPLATIN, European journal of cancer, 34(8), 1998, pp. 1295-1295
Authors:
KOUMAKIS G
ANAGNOSTOU D
HATZICHRISTOU H
TASSIDOU A
VASSILOMANOLAKIS M
BARBOUNIS V
FILIS J
PSARAS E
EFREMIDIS A
Citation: G. Koumakis et al., SEQUENTIAL EVALUATION OF MULTIPLE CYCLES OF HIGH-DOSE (HDCHE) CHEMOTHERAPY AND STEM-CELL TRANSPLANTATION (SCT) WITH PCR IN LYMPHOMA PATIENTS, Annals of oncology, 9, 1998, pp. 537-537
Authors:
SCULIER JP
PAESMANS M
THIRIAUX J
LECOMTE J
BUREAU G
GINER V
EFREMIDIS A
LAFITTE JJ
BERCHIER MC
ALEXOPOULOS CG
ZACHARIAS C
MOMMEN P
NINANE V
KLASTERSKY J
Citation: Jp. Sculier et al., PHASE-III RANDOMIZED TRIAL COMPARING CISPLATIN AND CARBOPLATIN WITH OR WITHOUT IFOSFAMIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1388-1396
Authors:
KOUMAKIS G
HATZICHRISTOU H
VASSILOMANOLAKIS M
BARBOUNIS V
PSARAS H
DEMIRI M
EFREMIDIS A
Citation: G. Koumakis et al., EVALUATION WITH PCR OF RESIDUAL MALIGNANT DISEASE IN PATIENTS WITH HL(1) FOLLOWING THE MOBILIZATION OF PBSC (2) FOLLOWING HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (HDSCHE), Bone marrow transplantation, 21, 1998, pp. 111-111
Authors:
PAPADHIMITRIOU SI
SPANAKOS G
FILIS I
BAXEVANIS CN
EFREMIDIS A
PAPAMICHAIL M
STAMATELOU M
Citation: Si. Papadhimitriou et al., PHENOTYPIC STUDY OF CD34+ CELLS IN POTENTIAL SOURCES OF TRANSPLANTS FOR MYELOMA, Bone marrow transplantation, 21, 1998, pp. 706-706
Authors:
HARZICHRISTOU H
BARBOUNIS V
KOUMAKIS G
VASSILOMANOLAKIS M
FILIS J
PAMOUKTSOGLOU F
PLATANIOTIS G
FOTIU S
MORAKI M
EFREMIDIS A
Citation: H. Harzichristou et al., HIGH-DOSE MELPHALAN AND PBSC IN ADVANCED OVARIAN-CARCINOMA, Bone marrow transplantation, 21, 1998, pp. 797-797
Authors:
KOUMAKIS G
HARZICHRISTOU H
FILIS J
VASSILOMANOLAKIS M
BARBOUNIS V
DEMIRI M
PSARAS H
EFREMIDIS A
Citation: G. Koumakis et al., DOSE-DEPENDENT MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) IN PATIENTS RECEIVING GLYCOSYLATED RHU-G-CSF, Bone marrow transplantation, 21, 1998, pp. 804-804
Authors:
VASSILOMANOLAKIS M
KOUMAKIS G
BARBOUNIS V
HAJICHRISTOU H
TSOUSIS S
EFREMIDIS A
Citation: M. Vassilomanolakis et al., A PHASE-II STUDY OF FLUTAMIDE IN OVARIAN-CANCER, Oncology, 54(3), 1997, pp. 199-202
Authors:
BARBOUNIS V
EFREMIDIS A
Citation: V. Barbounis et A. Efremidis, A PLASMA-CELL VARIANT OF CASTLEMANS DISEASE TREATED SUCCESSFULLY WITHCIMETIDINE - CASE-REPORT AND REVIEW OF THE LITERATURE, Anticancer research, 16(1), 1996, pp. 545-547
Authors:
KOUMAKIS G
HATZICHRISTOU H
VASSILOMANOLAKIS M
BARBOUNIS V
TSOUSIS S
EFREMIDIS A
Citation: G. Koumakis et al., PREVENTIVE VERSUS THERAPEUTIC USE OF G-CSF FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE (H,D,CTX), European journal of cancer, 31A, 1995, pp. 242-242
Authors:
KOUMAKIS G
FILIS J
MORAKI M
VASSILOMANOLAKIS M
HATZICHRISTOU H
KRITSIOTI M
PAPANASTASIOU K
BARBOUNIS V
TSOUSIS S
STAMATELLOU M
EFREMIDIS A
Citation: G. Koumakis et al., FACTORS AFFECTING ADEQUACY OF SINGLE VS MULTIPLE APHERESIS FOR STEM-CELL COLLECTION DURING MOBILIZATION FOR RESCUING PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 1122-1122
Authors:
SCULIER JP
KLASTERSKY J
GINER V
BUREAU G
THIRIAUX J
DABOUIS G
EFREMIDIS A
RIES F
BERCHIER MC
SERGYSELS R
MOMMEN P
PAESMANS M
Citation: Jp. Sculier et al., PHASE-II RANDOMIZED TRIAL COMPARING HIGH-DOSE CISPLATIN WITH MODERATE-DOSE CISPLATIN AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 353-359
Risultati:
1-12
|